Summary
Regulatory T cells (Tregs) control immune responses by suppressing various inflammatory cells. Tregs in newborn babies may play an important role in preventing excessive immune responses during their environmental change. We examined the number and phenotype of Tregs during the neonatal period in 49 newborn babies. Tregs were characterized by flow cytometry using cord blood (CB) and peripheral blood (PB) from the early (7–8 days after birth) and late (2–4 weeks after birth) neonatal periods. CD4+forkhead box protein 3 (FoxP3+) T cells were classified into resting Tregs (CD45RA+FoxP3low), activated Tregs (CD45RA– FoxP3high) and newly activated T cells (CD45RA– FoxP3low). Compared with CB and PB during the late neonatal period, the percentage of Tregs and all Treg subpopulations in the CD4+ lymphocyte population were increased significantly during the early neonatal period. Furthermore, the proportion and absolute number of activated Tregs were increased markedly compared with other Treg subpopulations, such as resting Tregs and newly activated T cells (non‐Tregs), in the early neonatal period. Increased Tregs concomitantly expressed the suppressive molecule cytotoxic T lymphocyte antigen‐4 (CTLA‐4). The up‐regulated expression of chemokine receptor 4 (CCR4) and down‐regulated expression of CCR7 were also observed in expanded Tregs. When cord blood cells were cultured in vitro with CD3 monoclonal antibodies (mAb) for 5 days, CD4+CD45RA–FoxP3high cells were increased significantly during the culture. Thus, the presence of increased activated Tregs in early neonates may play an important role in immunological regulation by suppressing excessive T cell activation caused by the immediate exposure to ubiquitous antigens after birth.
Keywords: FoxP3, immune regulation, neonates
Introduction
Regulatory T cells (Tregs) maintain immune homeostasis by suppressing the activation, proliferation and effector functions of a wide range of immune cells, including CD4+ and CD8+ T cells, natural killer (NK) cells, NK T cells, B cells and antigen‐presenting cells (APC). Tregs play an important role in diverse immune responses, with many investigations into pathophysiology identifying associations between Tregs and autoimmune disease, allergic disease and pregnancy 1.
In humans, Tregs were first characterized as CD4+CD25+ T cells, with forkhead box protein 3 (FoxP3) being identified later as the master controller of gene expression 2, 3; thus, Tregs are currently defined as CD4+CD25+FoxP3+ cells. However, it was reported recently that Tregs can be classified into three subpopulations based on their expression of CD4, CD45RA and FoxP3: resting Tregs (CD4+CD45RA+FoxP3low), activated Tregs (CD4+CD45RA–FoxP3high) and non‐Tregs (CD4+CD45RA–FoxP3low) 3. Non‐Tregs are described as newly activated T cells in this report because non‐Tregs contain CD4+FoxP3– T cells. Functional analysis of Treg subpopulations have been investigated in multiple disease states 3, 4, 5, 6. Both activated and resting Tregs have suppressive functions, and once resting Tregs are stimulated they differentiate into activated Tregs and proliferate. Conversely, newly activated T cells produce inflammatory cytokines and have no suppressive function 3.
Tregs first appear during fetal development in‐utero and increase more during the fetal period than after birth; thus, Tregs play a pivotal role in feto–maternal tolerance 7, 8, 9. The proportion of Tregs among CD4+ T cells decreases with gestational age 10, but it is less in the cord blood (CB) of full‐term infants than in adult peripheral blood (PB). A few days after birth, the Treg cell number increases to levels comparable to adult PB and remains stable thereafter, in the range of 5–10%. The components of the Treg cell population also change after birth. Effector type Tregs increase depending on age and predominate by puberty; however, most of the Tregs are naive at birth 11, 12, 13. Dynamic changes in chemokine receptor expression on Tregs accompany age‐related changes in activation 11.
Changes in the Treg cell population during adulthood have been reported; however, there are few reports showing the details of the Treg cell population during the neonatal period, when newborn babies are exposed to ubiquitous antigens after transfer from the intrauterine to the extrauterine environment. Fetuses develop in an almost sterile environment; however, newborn babies are exposed to ubiquitous antigen after birth. Excessive immune responses to environmental antigens can cause the onset of allergic diseases or inflammatory bowel disease. Indeed, affected individuals develop autoimmune disease and inflammatory bowel disease a few weeks after birth in the immunodysregulation polyendocrinopathy enteropathy X‐linked (IPEX) syndrome, which is due to a mutation in Foxp3 14, 15. Tregs in neonates probably play an important role in preventing excessive immune responses during the environmental changes faced by newborn babies. In this study, we examined the fluctuation of number and components of the Treg cell population in the neonatal period using flow cytometry and the in‐vitro induction of Tregs from CB cells.
Materials and methods
Subjects
Forty‐nine newborn babies were admitted to the Neonatal Intensive Care Unit (NICU) of Hiroshima University Hospital from November 2013 to December 2014. Any cases administered steroids after birth or suffering congenital malformation, sepsis, gastrointestinal complications or severe intraventricular hemorrhage were not included in the study.
Blood sample collection
CB was taken in heparinized or ethylenediamine tetraacetic acid (EDTA)‐coated tubes by umbilical venipuncture. PB of neonates was taken in EDTA‐coated microtainer tubes by heel stick during the early period (7–8 days after birth) and the late period (2–4 weeks after birth). The classification of late period was based on our initial experiments showing no significant difference in Tregs in peripheral blood at 2, 3 and 4 weeks of age (data not shown). Both CB and PB samples, during the early and late periods, were collected from each newborn baby enrolled into this study. Adult PB was taken in heparinized tubes by venipuncture. Samples in EDTA‐coated tubes were used for flow cytometric analysis and samples in heparinized tubes were used for culture experiments. Samples were analysed after obtaining informed consent from the babies’ guardians. This study was approved by the Ethics/International Review Board of Hiroshima University.
White blood cells (WBC) and regulatory T cells counts
Complete blood cell counts and differential white blood counts were measured on a XT‐4000i automated haematology analyser (Sysmex Corporation, Kobe, Japan). Absolute counts for Tregs were calculated by multiplying the percentages of Tregs in the lymphocyte gate by the number of circulating lymphocytes per μl blood.
Cell staining and flow cytometry
In total, 100 μl of whole blood was used per sample. Samples were analysed within 12 hours of collection. To remove red blood cells (RBCs), samples were treated with lysing solution (Easy‐Lyse™; Dako, Carpinteria, CA, USA) and the remaining cells were washed twice with phosphate‐buffered saline (PBS) and incubated at 4°C for 10 min with anti‐human monoclonal antibodies. Cells were surface stained with anti‐CD4 monoclonal antibodies (mAb) and anti‐CD25 mAb or both anti‐CD4 mAb and anti‐CD45RA mAb and stained intracellularly with FoxP3 or CTLA‐4. Intracellular staining was performed according to the manufacturer's instructions (Human FoxP3 Buffer Set; BD, Franklin Lakes, NJ, USA). The samples were analysed on a fluorescence activated cell sorter (FACS)Calibur or FACSVerse (BD Biosciences, San Jose, CA, USA) and data were analysed using BD Cell Quest Pro software and BD FACSuite™ software. The gates were set using isotype controls and single antibody controls were used to calculate the compensation.
Anti‐human mAbs used for this study
For cell surface staining; anti‐CD4‐fluorescein isothiocyanate (FITC) [mouse (Ms)] immunoglobulin (Ig)G1k, clone rat pancreatic amylase (RPA)‐T4; BD), anti‐CD‐25‐phycoerythrin (PE) (Ms IgG1k, M‐A251; BD), anti‐CD45RA‐PE (Ms IgG2b, T6D‐11; Miltenyi Biotec, San Diego, CA, USA), anti‐CD194 [CC chemokine receptor (CCR4)]‐Alexa Fluor 647 (Ms IgG1, 1G1; BD) and anti‐CD197 (CCR7)‐Alexa Fluor 647 (Ms IgG2a, 3D12; BD). For intracellular staining; anti‐FOXP3‐Alexa Fluor 647 (Ms IgG1, 259D/C7; BD), and anti‐CTLA‐4‐APC (Ms IgG2a, BNI3; BD).
In‐vitro differentiation of CD4+CD25+FoxP3+ cells and CD4+CD45RA–FoxP3high cells
Mononuclear cells (MNCs) from CB (n = 5) and healthy adult PB (n = 5) were separated by density gradient centrifugation (Lymphoprep™; Axis‐Shield, Dundee, UK). Subsequently, MNCs were cultured in RPMI‐1640 medium (Sigma‐Aldrich, St Louis, MO, USA) supplemented with 10% heat‐inactivated fetal bovine serum (FBS) and 100 μg/ml penicillin and streptomycin. For activation and proliferation experiments, cells were plated in 24‐well flat‐bottomed plates at a density of 5 × 105 cells/ml and stimulated with soluble anti‐CD3 mAb (100 ng/ml) [muromonab‐CD3 (OKT3); Miltenyi Biotec] + recombinant interleukin (rIL)‐2 (20 U/ml) (R&D Systems, Minneapolis, MN, USA) for 2 days. The cells were then washed and incubated with culture medium containing rIL‐2 (20 U/ml) for 3 more days. Cells were stained with anti‐CD4‐FITC, anti‐FoxP3‐Alexa Fluor®647 and anti‐CD45RA‐PE or anti‐CD25‐PE on the second and fifth days after starting cultivation. The percentage of CD4+CD25+FoxP3+ cells and CD4+CD45RA– FoxP3high cells of CD4+ cells were analysed by flow cytometry. Dead cells were identified using BD Horizon™ Fixable Viability Stain780 (BD).
Statistical analysis
Statistical analysis was performed using spss version 23 software (IBM SPSS Corporation, Armonk, NY, USA). To compare the three different age groups, CB and PB in the early and late neonatal period, repeated‐measure analysis of variance (anova) followed by Bonferroni correction or Friedman's test followed by Wilcoxon t‐test with Bonferroni correction were used. Spearman's correlation was used to analyse the correlation between gestational age or birth weight and Tregs or Treg subpopulations. For comparisons between groups, the Mann–Whitney U‐test was used. A value of P < 0·05 was considered statistically significant.
Results
Clinical characteristics of neonate participants
Forty‐nine neonates, including four sets of dichorionic diamniotic twins and two sets of monochorionic diamniotic twins, were enrolled into this study. Their clinical characteristics are shown in Table 1. All neonates were admitted to the NICU of Hiroshima University Hospital, accommodated in an infant incubator and received infusion of glucose and electrolyte solutions. None of the neonates received glucocorticoid steroid or immunoglobulin preparations, which may have affected their immune system after birth. Eighteen neonates received preventive antibiotics, none developed infectious disease and the administration of antibiotics was discontinued within 3 days. Enteral nutrition started soon after birth and establishment of nutrition was not delayed in any cases.
Table 1.
Characteristics of participating neonates
| n = 49 | |
|---|---|
| Gestational age (weeks, mean ± s.d.) | 30·9–37·0 (34·0 ± 1·6) |
| Birth weight (g, mean ± s.d.) | 1306–2947 (1983 ± 361) |
| APGAR score 5 min (mean ± s.d.) | 4–10 (9·08 ± 1·2) |
| Gender (%) | |
| Male | 24 (49) |
| Female | 25 (51) |
| Mode of delivery (%) | |
| Caesarean section | 29 (59) |
| Vaginal | 20 (41) |
| Antibiotics administration (%) | 18 (37) |
| Initiation time of feeding (day‐old, mean ± s.d.) | 0–1 (0·6 ± 0·5) |
| Feeding mode (%) | |
| Breastfeeding mainly | 20 (41) |
| Formula mainly | 29 (59) |
| Antenatal administration of corticosteroids (%) | 17 (35) |
| Antenatal administration of antibiotics (%) | 19 (39) |
| Antenatal administration of magnesium sulphate (%) | 15 (31) |
| Maternal allergic disease (%) | 13 (27) |
| Maternal smoking in pregnancy (%) | 6 (12) |
| Histological chorioamnionitis | 5 (10) |
APGAR = Appearance, Pulse, Grimace, Activity, Respiration; s.d. = standard deviation.
WBC and Treg counts
Absolute counts of Tregs in CB and PB during the early and late neonatal periods were measured using differential WBC counts in 36 newborn babies. Absolute counts for WBC and lymphocytes were not increased in the early neonatal period, whereas absolute counts of Tregs were increased significantly in the early neonatal period compared with those in CB and the late neonatal period (Fig. 1).
Figure 1.

Absolute counts for white blood cells, lymphocytes and regulatory T cells (Tregs). Absolute counts for Tregs were calculated by multiplying the percentage of Tregs in the lymphocyte gate by the absolute lymphocyte count and dividing by 100 (n = 36). **P < 0·01 (Friedman's test with post‐hoc tests). n.s., not significant.
Analysis of circulating total Tregs and Treg subpopulations in neonates
The percentage of total Tregs and Treg cell subpopulations in CD4+ lymphocytes in CB and PB of neonates is shown in Fig. 2a. Lymphocytes were identified initially by forward‐ and side‐scatter. Total Tregs were defined as CD4+CD25+FoxP3+ T cells. In the analysis of Treg cell subpopulations, CD4+ cells were classified by the expression of CD45RA and FoxP3 into three subpopulations, resting Tregs (CD4+CD45RA+FoxP3low), activated Tregs (CD4+CD45RA–FoxP3high) and newly activated T cells (CD4+CD45RA–FoxP3low) based on the differential expression of CD45RA and FoxP3. The percentage of total Tregs in CD4+ lymphocytes was increased significantly during the early neonatal period compared with Tregs in CB and PB during the late neonatal period (Fig. 2b). Next, we investigated changes within the Treg cell subpopulations (Fig. 2c). The proportion of all subpopulations in CD4+ lymphocytes was increased significantly in PB in the early neonatal period compared with CB and PB in the late neonatal period. Furthermore, activated Tregs were increased predominantly among the Treg cell subpopulations (Fig. 2d). Additionally, resting Tregs predominated during the late neonatal period, while the number of activated Tregs was comparable with resting Tregs during the early neonatal period. Newly activated T cells were increased in number during the early neonatal period and were reduced during the late neonatal period; however, the fluctuation in the number of newly activated T cells is small compared with other subpopulations. Thus, total Tregs were increased significantly in the early neonatal period through the predominant expansion of activated Tregs. Additionally, we investigated the proportion of effector (CD45RA–FoxP3–) CD4+ T cells and naive (CD45RA+FoxP3–) CD4+ T cells. The proportion of effector and naive CD4+ T cells decreased transiently in the early neonatal period, contrary to that of activated Tregs (Supporting information, Fig. S1).
Figure 2.

Fluctuation of regulatory T cells (Tregs) and Treg subpopulations during the neonatal period. Tregs (a) and Treg subpopulations (c) in cord blood (CB) or peripheral blood (PB) obtained during the early and late neonatal periods were measured by flow cytometry (n = 49). Data are also presented as box‐plots which display the minimum value, 25th, 50th and 75th percentiles and maximum value (b,d). *P < 0·05; **P < 0·01 [repeated‐measure analysis of variance (anova) post‐hoc test]. ##P < 0·01 (Friedman's test with post‐hoc tests). [Colour figure can be viewed at wileyonlinelibrary.com]
Expression of CTLA‐4 in CD4+CD25+ T cells and CD4+CD25+FoxP3+ Tregs
CTLA‐4 is a member of the immunoglobulin superfamily, which is expressed on CD4+ lymphocytes, transmitting an inhibitory signal to T cells. Similarly, CTLA‐4 is also expressed in Tregs and is important for Treg cell function 16. To confirm that the Tregs increased transiently in the early neonatal period potentially have suppressive function, the expression of CTLA‐4 on CD4+CD25+ lymphocytes was investigated (Fig. 3a). The numbers of CD4+CD25+CTLA‐4+ T cells, as well as Tregs and activated Tregs, increased significantly during the early neonatal period (Fig. 3b). The mean fluorescence intensity (MFI) of CTLA‐4 in CD4+CD25+FoxP3+ Tregs was measured in an additional four newborn babies (Fig. 3c). They were two male and two female babies, and their gestational ages were 33 weeks 6 days, 34 weeks 0 days, 36 weeks 1 day and 36 weeks 2 days, respectively (mean: 34 weeks 6 days). CTLA‐4 MFI of CD4+CD25+FoxP3+ Tregs was higher in the early neonatal period compared with that in CB and the late neonatal period (Fig. 3d). The expression of CTLA‐4 in Tregs increased similarly in all four cases.
Figure 3.

Cytotoxic T lymphocyte antigen‐4 (CTLA‐4) expression in CD4+CD25+ T cells and CD4+CD25+forkhead box protein 3 (FoxP3+) regulatory T cells (Tregs) during the neonatal period. CTLA‐4 expression was measured on CD4+CD25+ T cells from cord blood (CB) or peripheral blood (PB) obtained during the early or late neonatal periods (n = 49, a). Data are presented in the right‐hand box plot (b). The histograms show the CTLA‐4 expression on CD4+CD25+FoxP3+ Tregs in four additional newborn babies (c). Data are also presented as box‐plots (d). **P < 0·01 [repeated‐measure analysis of variance (anova) post‐hoc test]. [Colour figure can be viewed at wileyonlinelibrary.com]
Expression of CCR4 and CCR7 on CD4+CD25+ T cells
CC chemokine receptors, CCR4 and CCR7, are markers of mature or naive phenotype in Tregs 11. The expression of CCR4 increases while the expression of CCR7 decreases during the activation of T cells. To characterize the function of Tregs, CCR4 and CCR7 expression on CD4+CD25+ T cells and CD4+CD25high T cells was investigated by flow cytometry (Fig. 4a and Supporting information, Fig. S3). CD4+CD25high T cells were defined as the 2% of CD4+ T cells with the highest expression of CD25, which was reported previously as being a Treg cell‐enriched population 17. The expression of CCR4 on CD4+CD25+ T cells and CD4+CD25high T cells was increased significantly (Fig. 4b), while the expression of CCR7 was decreased during the early neonatal period compared with the late neonatal period (Fig. 4c). A significantly greater change was observed in the expression of CCR4 and CCR7 in CD4+CD25high T cells than CD4+CD25+ T cells during the neonatal period (Mann–Whitney U‐test, P < 0·01).
Figure 4.

Expression of CC chemokine receptor (CCR4 or CCR7) on CD4+CD25high T cells during the neonatal period. CCR4 and CCR7 expression on CD4+CD25– T cells, CD4+CD25+ T cells and CD4+CD25high T cells was investigated (n = 49). Data are displayed as representative histograms from the same baby (a) and box‐plots (b). **P < 0·01 (Friedman's post‐hoc tests). [Colour figure can be viewed at wileyonlinelibrary.com]
In‐vitro differentiation of CD4+CD25+FoxP3+ cells and CD4+CD45RA–FoxP3high cells
A marked change in the total Treg cell numbers, including Treg cell subpopulations, and CTLA‐4, CCR4 and CCR7 expression in CD4+CD25+ cells was observed during the neonatal period. Based on these results, we hypothesized that CD4+ T cells from CB might differentiate efficiently into FoxP3+ Tregs.
CB and adult PB MNCs were activated in the presence of anti‐CD3 mAb and rIL‐2 for 2 days, followed by culture with rIL‐2 for a further 3 days. The induction of FoxP3 expression in CD4+ cells was observed in MNCs derived from both CB and adult PB by stimulation with anti‐CD3 mAb (Supporting information, Fig. S4). The induction of FoxP3 was more pronounced in CB compared with adult PB (Fig. 5a,b). Analysis of the Treg cell subpopulations revealed that CD4+ FoxP3+ cells from CB MNCs differentiated from naive to effector cells following stimulation with anti‐CD3 mAb and CD4+CD45RA–FoxP3high cells from CB MNCs increased significantly compared with adult PBMNCs after 2 and 5 days of culture (Fig. 5b).
Figure 5.

In‐vitro differentiation of cord blood (CB) CD4+ T cells into CD25+FoxP3+ T cells. CB or peripheral blood (PB) mononuclear cells were cultured in the presence of anti‐CD3 monoclonal antibodies (mAb) and recombinant interleukin (rIL‐2) for 2 days followed by rIL‐2 for a further 3 days. The expression of CD25 and forkhead box protein 3 (FoxP3) was analysed by flow cytometry after a total of 5 days in culture. Data are displayed as representative flow cytometry plots (a) and as the mean ± standard deviation (s.d.) (b). *P < 0·05 (Mann–Whitney U‐test). [Colour figure can be viewed at wileyonlinelibrary.com]
Factors associated with changes in Tregs
Various factors potentially associated with the change in Treg cell numbers were examined in this study. We compared gestational age, birth weight, APGAR (Appearance, Pulse, Grimace, Activity, Respiration) score 5 min, gender, mode of delivery, antibiotic administration, initiation time of feeding, feeding mode, antenatal administration of corticosteroids, antenatal administration of antibiotics, antenatal administration of magnesium sulphate, maternal allergic disease, maternal smoking in pregnancy and histological chorioamnionitis to identify potential factors affecting Treg cell numbers. Tregs in CB were correlated negatively with birth weight and gestational age, although Tregs in the early and late neonatal periods were not correlated with these factors. In Treg cell subpopulations, activated Tregs in CB were correlated negatively with gestational age. Resting Tregs in CB were correlated negatively with birth weight (Fig. 6a and Supporting information, Fig. S5). Considering other factors, administration of antenatal corticosteroid increased Tregs significantly in CB and PB during the late neonatal period. Administration of antenatal antibiotics decreased Tregs significantly and activated Tregs in PB during the early neonatal period (Fig. 6b). Histological chorioamnionitis decreased Tregs significantly and activated Tregs PB during the early neonatal period (Supporting information, Fig. S6). In contrast, we did not see an obvious difference in the total number of Tregs and their subpopulations in CB and PB during the late neonatal period.
Figure 6.

Factors associated with the change in regulatory T cells (Tregs) and Treg subpopulations. Association analysis of the percentages of Tregs in CD4+ lymphocytes and gestational age or birth weight were performed (a). The effect of corticosteroid or antibiotic administration on the percentage of total Tregs and activated Tregs was analysed. Data are shown as box‐plots (b). *P < 0·05; **P < 0·01 (Mann–Whitney U‐test). n.s., not significant.
Discussion
Tregs are a subpopulation of the CD4+ T cell subset, which suppress the immune responses of inflammatory cells, particularly during autoimmune and allergic diseases. Tregs emerge at approximately 13 weeks of gestation 18, 19, and the increased number of Tregs present in the second trimester plays a pivotal role in feto–maternal tolerance 7. Subsequently, the number of Tregs decreases with gestational age 10 and increases after birth with the attainment of adult proportions within a few days 11, 12. In this study, the Treg cell population of total CD4+ cells during the early neonatal period was increased transiently when compared with cells from both CB and PB during the late neonatal period. This is the first report to show a transient, but striking, increase in Tregs in the early neonatal period.
To study the suppressive function of the Tregs in early neonates, Tregs were separated further based on phenotypical differences. It has been reported that CD4+ cells are classified phenotypically and/or functionally into three subpopulations, resting Tregs, activated Tregs and newly activated T cells. Both resting and activated Tregs are capable of suppressing an immune response 3. The resting Tregs, once stimulated, proliferate, becoming activated Tregs possessing strong suppressive ability. Conversely, newly activated T cells typically produce inflammatory cytokines without immunosuppressive activity 3. Our results demonstrated that Treg cell numbers augmented in early neonates comprised predominantly activated Tregs, as shown in Fig. 1. Therefore, the increased Tregs in early neonates may be responsible for suppression of the immune response during the neonatal period. Mayer et al. 20 demonstrated that CB‐derived Tregs possess the ability to become highly suppressive upon antigen exposure and that early exposure to innocuous antigen is vital to develop T cell tolerance. The proportion of effector and naive CD4+ T cells was decreased transiently during the early neonatal period, contrary to that of activated Tregs. Therefore, we hypothesize that increased activated Tregs during the early neonatal period cannot be explained by global T cell activation. Thus, the increase of Tregs with suppressive function in early neonates may play a pivotal role in regulating immune response for adapting to environmental antigens as early as a week after birth.
CTLA‐4 is a member of the immunoglobulin superfamily that is expressed on CD4+ cells to transmit an inhibitory signal to T cells. In addition, CTLA‐4 is expressed highly on Tregs and comprises one of the mechanisms of Treg cell‐mediated immune suppression 16. Recently, germline heterozygous mutations in the CTLA4 gene were identified in patients with primary immunodeficiency presenting as the dysregulation of FoxP3+ Tregs. Thus, CTLA‐4 is considered to play an important role in Treg cell‐mediated host immune regulation in humans 21, 22. The increase of CD4+CD25+CTLA‐4+ T cells, as well as Tregs and activated Tregs, observed in this study suggests the requirement of immunosuppression through these T cells during the early neonatal period.
Tregs undergo programmed switches in migratory behaviour during their development and activation 23. Tregs generated in the thymus highly express homing receptors for emigration to secondary lymphoid tissues. Simulating antigen presentation was shown to induce a decrease in the expression of second lymphoid tissue homing receptors and an increase in the expression of memory/effector chemokine receptors 23. To confirm the functional change in Tregs in the neonatal period, the expression of chemokine receptors CCR4 and CCR7 on CD4+CD25high T cells was examined. The expression of homing receptors CCR4 and CCR7 on Tregs is associated with the differentiation of Tregs from naive to effector cells 11, 23. Our results showed an increase in the expression of CCR4 and a concomitant decrease in the expression of CCR7 on CD4+CD25high T cells during the early neonatal period. This evidence confirms further that augmented CD4+CD25high T cell numbers in early neonates possess an immune phenotype consistent with activated Tregs expressing CTLA‐4.
Recently, Lee et al. proposed a layered immune system hypothesis for the change of T cells from tolerogenic to immunogenic during the development of a fetus to an adult. Gene expression profiles of Tregs and T cells in a fetus differ from expression in adults, suggesting that fetal T cells play a role in immunotolerance 7, 24. CD4+CD25–CD45RO– naive T cells isolated from peripheral blood in neonates were shown to be more functionally active Tregs than those present during adulthood, when naive T cells were cultured with APCs in vitro 25, 26. Our study showed that the expression of FoxP3 in CD4+ lymphocytes induced by the stimulation of CB MNCs with anti‐CD3 mAb was much higher than FoxP3 expression induced in adult PB MNCs. Collectively, T cells in CB consisting primarily of naive T cells are probably predisposed to respond to stimulation by environmental antigens, resulting in the immunotolerance seen in neonates through the functionally activated Tregs possessing strong immunosuppressive tendencies.
Various factors have the potential to modulate the ontogenic development of Tregs. Such factors in neonates include gestational age, intestinal microbiota, Toll‐like receptor (TLR)‐2 polymorphisms and IL‐10 polymorphisms, while the maternal factors include smoking in pregnancy, allergic disease and chorioamnionitis 10, 27, 28, 29, 30, 31, 32, 33, 34, 35. A negative correlation between gestational age and Treg cell development shown in this study using CB was consistent with previous reports. This study showed the involvement of antenatal maternal administration of antibiotics and histological chorioamnionitis in the decreased Treg cell number in early neonates. Thus, further studies are necessary to elucidate the factors, which may affect the development of Tregs during the fetal and neonatal period.
This study was designed with the care of premature infants as the end objective. The limited results from mature neonates who were hospitalized in NICU have demonstrated a similar fluctuation of Tregs to that presented in this study (data not shown). These findings suggest that the characteristic change of proportion of Tregs may be observed during the first 14 days in neonates. Further studies are required to confirm the conclusion of a transient increase of activated Treg in mature and full‐term infants.
This study clearly showed changes in the proportion and absolute number of Tregs in the early neonatal period. However, we have not investigated the suppressive function of these increased Tregs during the early neonatal period because of the limited number of cells available. Previous studies revealed that Tregs in CB from preterm infants have lower activity than those in CB from term infants and adult PB 36, 37, 38. The difference in the function of Treg due to prematurity may affect the frequency of Tregs and its subpopulations during the neonatal period. Additionally, a previous study suggested that the function of Tregs in CB was impaired in the case with severe chorioamnionitis 35. In the current study, cases with histological chorioamnionitis showed a significantly lower frequency of Tregs and activated Tregs during the early neonatal period. The decrease of Tregs and activated Tregs may reflect the impaired Treg function of CB in chorioamnionitis cases. The evaluation of qualitative and quantitative change of Tregs during the early neonatal period may be necessary to clarify the role of Tregs in neonates because phenotypical differences and differences in function are not always the same.
In conclusion, the numbers of total Tregs were increased significantly during the early neonatal period, comprising predominantly activated Tregs. CD4+CD25+CTLA‐4+ T cells were also increased significantly during the early neonatal period, consistent with elevated Tregs and activated Treg cell numbers, suggesting suppressive immune regulation by T cells in early neonates. The increased expression of CCR4 and decreased expression of CCR7 on CD4+CD25high T cells implied the activation of Tregs in the early neonatal period. CD4+CD25+ FoxP3+ T cells were induced transiently when MNCs from CB and from adult PB were cultured in vitro with anti‐CD3 mAb and rIL‐2. The percentage of CD4+CD25+FoxP3+ T cells induced from CB was higher than from adult PB. The naive nature of CB suggests that lymphocytes in CB may be more attuned to becoming Tregs when encountering the appropriate stimulation. These results suggest that the increase in Tregs and their function in early neonates may play an important role in early immune suppression required for adapting to environmental change encountered after birth.
Disclosure
The authors have declared no disclosures.
Supporting information
Additional Supporting information may be found in the online version of this article at the publisher's web‐site:
Fig. S1. Fluctuation of naive CD4+ T cells and effector CD4+ T cells during the neonatal period. Naive T cells are defined as CD4+CD45RA+forkhead box protein 3 (FoxP3–) cells and effector T cells are defined as CD4+CD45RA–FoxP3– cells in this figure. Data are presented as box plots. #P < 0·05; ##P < 0·01 (Friedman's test with post‐hoc tests).
Fig. S2. Association analysis between the percentages of CD4+CD25+cytotoxic T lymphocyte antigen‐4 (CTLA‐4+) cells and gestational age were performed. Rs = correlation coefficients (Spearman's rank correlation coefficient).
Fig. S3. Expression of CC chemokine receptor (CCR)4 or CCR7 on CD4+ T cells during the neonatal period. Data are displayed as representative dot‐plots.
Fig. S4. In‐vitro differentiation of the mononuclear cells (MNCs) stimulated by anti‐CD3 monoclonal antibodies (mAb) and unstimulated CD4+ cells in cord blood (CB) or adult peripheral blood (PB) into CD25+forkhead box protein 3 (FoxP3+) T cells. Data are displayed as the mean ± standard deviation (s.d.).
Fig. S5. Association analysis between the percentages of resting or activated regulatory T cells (Tregs) and gestational age or birth weight were performed. Rs = correlation coefficients (Spearman's rank correlation coefficient).
Fig. S6. Effect of histological chorioamnionitis on the percentage of total regulatory T cells (Tregs) and activated Tregs was analysed. Data are shown as box‐plots. *P < 0·05; **P < 0·01 (Mann–Whitney U‐test).
Acknowledgements
We are grateful to the Department of Pathology clinical laboratory affiliated with Hiroshima University Hospital for measurement of complete blood cell counts and differential white blood counts. Flow cytometry analysis was supported in part by the Department of Blood Transfusion affiliated with Hiroshima University Hospital. S. H. planned and performed experiments, analysed data and wrote the paper. N. O. planned experiments and provided experimental help. S. O. and M. K. discussed the results and revised the paper.
References
- 1. Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10:490–500. [DOI] [PubMed] [Google Scholar]
- 2. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057–61. [DOI] [PubMed] [Google Scholar]
- 3. Miyara M, Yoshioka Y, Kitoh A et al Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009; 30:899–911. [DOI] [PubMed] [Google Scholar]
- 4. Rieux‐Laucat F, Pan X, Yuan X et al Increased CD45RA+FoxP3low regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus. PLOS ONE 2012; 7:e34662. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Haseda F, Imagawa A, Murase‐Mishiba Y, Terasaki J, Hanafusa T. CD4(+) CD45RA(–) FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin‐secreting capacity in patients with type 1 diabetes. Clin Exp Immunol 2013; 173:207–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Miyara M, Sakaguchi S. Human FoxP3+CD4+ regulatory T cells: their knowns and unknowns. Immunol Cell Biol 2011; 89:346–51. [DOI] [PubMed] [Google Scholar]
- 7. Burt TD. Fetal regulatory T cells and peripheral immune tolerance in utero: implications for development and disease. Am J Reprod Immunol 2013; 69:346–58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Michaëlsson J, Mold JE, McCune JM, Nixon DF. Regulation of T cell responses in the developing human fetus. J Immunol 2006; 176:5741–8. [DOI] [PubMed] [Google Scholar]
- 9. Mold JE, Michaëlsson J, Burt TD et al Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero . Science 2008; 322:1562–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Takahata Y, Nomura A, Takada H et al CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene. Exp Hematol 2004; 32:622–9. [DOI] [PubMed] [Google Scholar]
- 11. Grindebacke H, Stenstad H, Quiding‐Jarbrink M et al Dynamic development of homing receptor expression and memory cell differentiation of infant CD4+CD25high regulatory T cells. J Immunol 2009; 183:4360–70. [DOI] [PubMed] [Google Scholar]
- 12. Fuchizawa T, Adachi Y, Ito Y et al Developmental changes of FOXP3‐expressing CD4+CD25+ regulatory T cells and their impairment in patients with FOXP3 gene mutations. Clin Immunol 2007; 125:237–46. [DOI] [PubMed] [Google Scholar]
- 13. Santner‐Nanan B, Seddiki N, Zhu E et al Accelerated age‐dependent transition of human regulatory T cells to effector memory phenotype. Int Immunol 2008; 20:375–83. [DOI] [PubMed] [Google Scholar]
- 14. Bennett CL, Christie J, Ramsdell F et al The immune dysregulation, polyendocrinopathy, enteropathy, X‐linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27:20–1. [DOI] [PubMed] [Google Scholar]
- 15. Wildin RS, Smyk‐Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002; 39:537–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Walker LS. Treg and CTLA‐4: two intertwining pathways to immune tolerance. J Autoimmun 2013; 45:49–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Baecher‐Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001; 167:1245–53. [DOI] [PubMed] [Google Scholar]
- 18. Cupedo T, Nagasawa M, Weijer K, Blom B, Spits H. Development and activation of regulatory T cells in the human fetus. Eur J Immunol 2005; 35:383–90. [DOI] [PubMed] [Google Scholar]
- 19. Darrasse‐Jeze G, Marodon G, Salomon BL, Catala M, Klatzmann D. Ontogeny of CD4+CD25+ regulatory/suppressor T cells in human fetuses. Blood 2005; 105:4715–21. [DOI] [PubMed] [Google Scholar]
- 20. Mayer E, Bannert C, Gruber S et al Cord blood derived CD4+ CD25(high) T cells become functional regulatory T cells upon antigen encounter. PLoS One 2012; 7:e29355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Schubert D, Bode C, Kenefeck R et al Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med 2014; 20:1410–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Kuehn HS, Ouyang W, Lo B et al Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science 2014; 345:1623–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Lee JH, Kang SG, Kim CH. FoxP3+ T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues. J Immunol 2007; 178:301–11. [DOI] [PubMed] [Google Scholar]
- 24. Mold JE, Venkatasubrahmanyam S, Burt TD et al Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans. Science 2010; 330:1695–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Wang G, Miyahara Y, Guo Z, Khattar M, Stepkowski SM, Chen W. ‘Default’ generation of neonatal regulatory T cells. J Immunol 2010; 185:71–8. [DOI] [PubMed] [Google Scholar]
- 26. de Roock S, Hoeks SBEA, Meurs L et al Critical role for programmed death 1 signaling and protein kinase B in augmented regulatory T‐cell induction in cord blood. J Allergy Clin Immunol 2011; 128:1369–71. [DOI] [PubMed] [Google Scholar]
- 27. Atarashi K, Tanoue T, Oshima K et al Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013; 500:232–6. [DOI] [PubMed] [Google Scholar]
- 28. Rabe H, Nordström I, Andersson K, Lundell AC, Rudin A. Staphylococcus aureus convert neonatal conventional CD4(+) T cells into FOXP3(+) CD25(+) CD127(low) T cells via the PD‐1/PD‐L1 axis. Immunology 2014; 141:467–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Liu J, Rädler D, Illi S et al TLR2 polymorphisms influence neonatal regulatory T cells depending on maternal atopy. Allergy 2011; 66:1020–9. [DOI] [PubMed] [Google Scholar]
- 30. Raedler D, Illi S, Pinto LA et al IL10 polymorphisms influence neonatal immune responses, atopic dermatitis, and wheeze at age 3 years. J Allergy Clin Immunol 2013; 131:789–96. [DOI] [PubMed] [Google Scholar]
- 31. Fu Y, Lou H, Wang C et al T cell subsets in cord blood are influenced by maternal allergy and associated with atopic dermatitis. Pediatr Allergy Immunol 2013; 24:178–86. [DOI] [PubMed] [Google Scholar]
- 32. Hinz D, Bauer M, Roder S et al Cord blood Tregs with stable FOXP3 expression are influenced by prenatal environment and associated with atopic dermatitis at the age of one year. Allergy 2012; 67:380–9. [DOI] [PubMed] [Google Scholar]
- 33. Unutmaz D, Lu L, Zhou X, Wang J, Zheng SG, Horwitz DA. Characterization of protective human CD4+CD25+ FOXP3+ regulatory T cells generated with IL‐2, TGF‐β and retinoic acid. PLOS ONE 2010; 5:e15150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Pagel J, Hartz A, Figge J et al Regulatory T cell frequencies are increased in preterm infants with clinical early‐onset sepsis. Clin Exp Immunol 2016; 185:219–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Rueda CM, Wells CB, Gisslen T, Jobe AH, Kallapur SG, Chougnet CA. Effect of chorioamnionitis on regulatory T cells in moderate/late preterm neonates. Hum Immunol 2015; 76:65–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Ly NP, Ruiz‐Perez B, McLoughlin RM et al Characterization of regulatory T cells in urban newborns. Clin Mol Allergy 2009; 7:8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Mukhopadhyay D, Weaver L, Tobin R et al Intrauterine growth restriction and prematurity influence regulatory T cell development in newborns. J Pediatr Surg 2014; 49:727–32. [DOI] [PubMed] [Google Scholar]
- 38. Rueda CM, Moreno‐Fernandez ME, Jackson CM, Kallapur SG, Jobe AH, Chougnet CA. Neonatal regulatory T cells have reduced capacity to suppress dendritic cell function. Eur J Immunol 2015; 45:2582–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Additional Supporting information may be found in the online version of this article at the publisher's web‐site:
Fig. S1. Fluctuation of naive CD4+ T cells and effector CD4+ T cells during the neonatal period. Naive T cells are defined as CD4+CD45RA+forkhead box protein 3 (FoxP3–) cells and effector T cells are defined as CD4+CD45RA–FoxP3– cells in this figure. Data are presented as box plots. #P < 0·05; ##P < 0·01 (Friedman's test with post‐hoc tests).
Fig. S2. Association analysis between the percentages of CD4+CD25+cytotoxic T lymphocyte antigen‐4 (CTLA‐4+) cells and gestational age were performed. Rs = correlation coefficients (Spearman's rank correlation coefficient).
Fig. S3. Expression of CC chemokine receptor (CCR)4 or CCR7 on CD4+ T cells during the neonatal period. Data are displayed as representative dot‐plots.
Fig. S4. In‐vitro differentiation of the mononuclear cells (MNCs) stimulated by anti‐CD3 monoclonal antibodies (mAb) and unstimulated CD4+ cells in cord blood (CB) or adult peripheral blood (PB) into CD25+forkhead box protein 3 (FoxP3+) T cells. Data are displayed as the mean ± standard deviation (s.d.).
Fig. S5. Association analysis between the percentages of resting or activated regulatory T cells (Tregs) and gestational age or birth weight were performed. Rs = correlation coefficients (Spearman's rank correlation coefficient).
Fig. S6. Effect of histological chorioamnionitis on the percentage of total regulatory T cells (Tregs) and activated Tregs was analysed. Data are shown as box‐plots. *P < 0·05; **P < 0·01 (Mann–Whitney U‐test).
